Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories

Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests

(2018) Shelley A. Campeau et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacodynamics of Daptomycin Against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model

(2018) James M. Kidd et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

21st Century Cures Act and Antimicrobial Susceptibility Testing: Clinical Implications in the Era of Multidrug Resistance

(2018) Romney M Humphries et al.   CLINICAL INFECTIOUS DISEASES

Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: A systematic review and meta-analysis of randomized controlled trials

(2018) M. Tandan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls

(2018) Romney M. Humphries et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

(2018) Patrick N. A. Harris et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, But Closer Attention from Regulatory Bodies is Needed.

(2018) James A. McKinnell et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae

(2016) Sarah M. Bartsch et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Antimicrobial Stewardship in the Microbiology Laboratory: Impact of Selective Susceptibility Reporting on Ciprofloxacin Utilization and Susceptibility of Gram-Negative Isolates to Ciprofloxacin in a Hospital Setting

(2016) B. J. Langford et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluation of Surrogate Disk Tests for Detection of Ciprofloxacin and Levofloxacin Resistance in Clinical Isolates of Salmonella enterica

(2015) Eszter Deak et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical Outcomes of Enterobacteriaceae Infections Stratified by Carbapenem MICs

(2014) Twisha S. Patel et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Performance of Etest and Disk Diffusion for Detection of Ciprofloxacin and Levofloxacin Resistance in Salmonella enterica

(2014) Eszter Deak et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Background and Rationale for Revised Clinical and Laboratory Standards Institute Interpretive Criteria (Breakpoints) for Enterobacteriaceae andPseudomonas aeruginosa:I. Cephalosporins and Aztreonam

(2013) Michael N. Dudley et al.   CLINICAL INFECTIOUS DISEASES

A Current Perspective on Daptomycin for the Clinical Microbiologist

(2013) R. M. Humphries et al.   CLINICAL MICROBIOLOGY REVIEWS

Cefazolin as a class representative for oral cephalosporins and uncomplicated urinary tract infections caused by indicated Enterobacteriaceae

(2013) Audrey N. Schuetz et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In Vitro Susceptibility Testing of Fluoroquinolone Activity Against Salmonella: Recent Changes to CLSI Standards

(2012) R. M. Humphries et al.   CLINICAL INFECTIOUS DISEASES

Putting the New CLSI Cephalosporin and Carbapenem Breakpoint Changes Into Practice in Clinical Microbiology Laboratories

(2012) J. H. Jorgensen   Journal of the Pediatric Infectious Diseases Society

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

(2011) Kalpana Gupta et al.   CLINICAL INFECTIOUS DISEASES

Outcomes of Bacteremia due to Pseudomonas aeruginosa with Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the Appropriateness of the Resistance Breakpoint

(2008) V. H. Tam et al.   CLINICAL INFECTIOUS DISEASES